Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia

The retinoic acid receptor alpha (RARA) gene is disrupted by PML/RARA fusion in acute promyelocytic leukemia (APL). The P2 promoter of RARA, controlling the RARα2 isoform, contains an RA-responsive element and may be targeted in APL. To test whether aberrant methylation of P2 was involved, 47 APL at diagnosis, 16 APL at first relapse, 50 acute myeloid leukemia (AML) and 22 acute lymphoblastic leukemia (ALL) were tested by methylation-specific polymerase chain reaction. RARA P2 methylation was highly associated with APL (APL: 25/63 vs AML/ALL: 2/75, P<0.0001). P2 methylation occurred at similar frequencies in APL at diagnosis and relapse, suggesting it was an initiating leukemogenic event. In the APL line NB4, RARα2 was not expressed, with the untranslocated RARA shown to be P2 methylated. 5-Azacytadine treatment of NB4 led to progressive P2 demethylation and re-expression of RARα2, confirming that RARA methylation collaborated with PML/RARA in totally suppressing RARα. In APL, RARA P2 methylation was unrelated to gender, age, presenting leukocyte counts and additional cytogenetic aberrations. For APL patients receiving all-trans retinoic acid for induction, P2 methylation did not affect the complete remission rates and survivals. RARA is the first myeloid-specific transcription factor shown to be dysregulated by both translocation and aberrant methylation.

[1]  Y. Kwong,et al.  Methylation of p15 and p16 genes in adult acute leukemia , 2001, Cancer.

[2]  P. Chambon,et al.  Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.

[3]  T. Enver,et al.  Lineage restriction of the RARα gene expression in myeloid differentiation , 2001 .

[4]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[5]  T. Enver,et al.  Lineage restriction of the RARalpha gene expression in myeloid differentiation. , 2001, Blood.

[6]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[7]  Y. Kwong,et al.  SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. , 2004, Blood.

[8]  H. de Thé,et al.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.

[9]  J. Licht,et al.  Translocations of the RARa gene in acute promyelocytic leukemia , 2001 .

[10]  I. Weissman,et al.  A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .

[11]  Y. Kwong,et al.  Absence of p300 gene promoter methylation in acute leukemia. , 2004, Cancer genetics and cytogenetics.

[12]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[13]  R. Liang,et al.  Hypermethylation of gene promoters in hematological neoplasia , 2002, Hematological oncology.

[14]  Y. Kwong,et al.  Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias , 2003, Annals of Hematology.

[15]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[16]  A. Wolffe,et al.  DNA methylation in health and disease , 2000, Nature Reviews Genetics.

[17]  C. Tribioli,et al.  Acute leukemia with promyelocytic features in PML/RARα transgenic mice , 1997 .

[18]  J. Licht,et al.  Translocations of the RARα gene in acute promyelocytic leukemia , 2001, Oncogene.

[19]  T. Hoang,et al.  Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. , 1998, Blood.

[20]  A. Chumakov,et al.  Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). , 1997, Blood.

[21]  P. Pandolfi.  In vivo analysis of the molecular genetics of acute promyelocytic leukemia , 2001, Oncogene.

[22]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[23]  I. Bleiweiss,et al.  Retinoic acid receptor α2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells , 2002 .

[24]  S. Collins.  The role of retinoids and retinoic acid receptors in normal hematopoiesis , 2002, Leukemia.

[25]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[26]  H. Berghe.  Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Second MIC Cooperative Study Group. , 1988, British journal of haematology.

[27]  Javier Benitez,et al.  Cancer Epigenetics and Methylation , 2002, Science.

[28]  I. Bleiweiss,et al.  Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  W. Au,et al.  Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. , 2004, Leukemia research.

[30]  T. Naoe,et al.  Analysis of the joining sequences of the t(15;17) translocation in human acute promyelocytic leukemia: Sequence non‐specific recombination between the pml and rara genes within identical short stretches , 1995, Genes, chromosomes & cancer.

[31]  A. Knudson,et al.  Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.

[32]  Howard Cedar,et al.  DNA methylation represses transcription in vivo , 1999, Nature Genetics.

[33]  J. Licht,et al.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.

[34]  R. Singal,et al.  DNA methylation. , 1999, Blood.

[35]  C. Tribioli,et al.  Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Weissman,et al.  A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[38]  Y. Kwong,et al.  Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance , 2003, British journal of haematology.

[39]  Y. Kwong,et al.  Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia , 2002, British journal of haematology.

[40]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Minucci,et al.  Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.

[42]  P. Pelicci,et al.  Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. , 1996, Blood.

[43]  R. Liang,et al.  Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  T. Hoang,et al.  Impaired Granulocytic Differentiation In Vitro in Hematopoietic Cells Lacking Retinoic Acid Receptors α1 and γ , 1998 .